
Clarifi Communications - Part of the Clarifi Group
Clarifi Communication helps professionals, scientists, and teams develop clear, confident English — for meetings, presentations, and cross-cultural collaboration.
Part of the Clarifi Group
We provide tailored communication training for real-world performance, not textbook grammar.Programs include:- Business English for corporate teams
- Scientific and technical English for researchers
- Presentation & meeting skills
- Confidence coaching for non-native speakers
- Practical language skills for a global professional world.

CLARIFI.FI
Founder Stephen O’Rourke has trained professionals across banking, science, logistics, and real estate — including:- M.M Warburg & Co (Private Investment Bank)
- University of Kiel (Academia)
- AXO DRESDEN (Biotech)
- HIH Real Estate Agency
- Bertelsmann SE & Co. KGaA (Logistics)
- Kühne + Nagel Management AG (Logistics)Real corporate experience means real-world relevance.

CLARIFI.FI
Clarifi Communication combines linguistic training with scientific and regulatory expertise — so participants gain not only better English but also the confidence to present complex ideas clearly and credibly.

CLARIFI.FI
- Corporate teams working internationally
- Scientists & researchers presenting findings
- Startups pitching to investors
- Professionals seeking clearer English communication

Ready to upgrade how you communicate and present your ideas?Let’s plan your next training session.Get in touch below or at info(at)clarifi.fi
Insights and features on how regulation, innovation, and startup strategy intersect — from MedTech to FoodTech and beyond.Startups don’t just need tech leads: They need an integrator.
Feature for EU-Startups
Read →Confidential by Default? The Transparency Dilemma in Europe’s Novel Foods System.
Feature for Green Queen Media
Read →From Gatekeeping to Guiding: The Case for Collaborative Regulation in Mission-Driven Innovation
White Paper in Collaboration with GCI
Read →Digital Health Meets Red Tape: What Pharma Can Learn from Software as a Medical Device
The role of SaMD in pharma covering regulations, AI/ML risks, compliance, and digital health strategies.
Feature for PharmaNow
Read →Lessons from a €50 million Series B: And why it matters at every startup funding stage
Feature for EU-Startups
Read →What does Gourmey’s regulatory milestone mean for cell-cultivated meat?
Interviewed by FI Global Insights
Read →Why EU Innovators Face Growing Barriers With EU Combination Product Regulation
Interviewed by Medtech Insight
Read →From WHOOP to DiGA: Where the Wellness Line Becomes a Regulatory Minefield
Feature for Test Labs UK Outlook
Read →Guest article: EU novel food delays. Why bureaucracy is choking off food innovation
Feature for AgFunder News
Read →How AI can get your novel food approved faster
Interviewed by FoodNavigator Europe
Read →Apple vs WHOOP: Two Blood Pressure Strategies, Two Very Different Regulatory Journeys
Feature for Test Labs UK Outlook
Read →For interviews, collaborations, or speaking opportunities, contact info(at)clarifi.fi
© 2025 Clarifi OyPart of Clarifi Oy — Regulatory | Strategy | Marketing | Ghostwriting | Grants | Policy & Advocacy | Communication | Career CoachingHelsinki, Finland / Suomi | Y-tunnus 3565244-7This website does not use cookies or analytics tracking.